NCT02148107View on ClinicalTrials.gov

Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy
Interventions
DRUG

BI 691751

BI 691751 Dose 1

DRUG

BI 691751

BI 691751 Dose 2

DRUG

BI 691751

BI 691751 Dose 3

DRUG

BI 691751

BI 691751 Dose 4

DRUG

BI 691751

BI 691751 Dose 5

DRUG

BI 691751

BI 691751 Dose 6

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

1334.2.1 Boehringer Ingelheim Investigational Site, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02148107 - Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter